related documents
- A Randomized Controlled Trial of Continued versus Interrupted Novel Oral Anti-Coagulant at the Time of Device Surgery (BRUISE CONTROL-2) Conference Paper
- ANNEXA (TM)-R Part 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Sustained Reversal of Rivaroxaban-Induced Anticoagulation in Older Subjects by Andexanet Alfa (PRT064445), a Universal Antidote for Factor XA (FXA) Inhibitors Conference Paper
- Atrial Substrate Modification With Aggressive Blood Pressure Control to Prevent Atrial Fibrillation (SMAC AF) Conference Paper
- Comparison of Cardiac Computerized Tomography Angiography and Transesophageal Echocardiography for Device Surveillance After Endovascular Left Atrial Appendage Closure Conference Paper
- Comparison of Contemporary Bleeding Risk Scores in Patients With Non-Valvular Atrial Fibrillation Treated With Dabigatran or Warfarin: Insights From the RE-LY Trial Conference Paper
- Costs Impact Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial Conference Paper
- Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study Conference Paper
- Idarucizumab in Dabigatran-Treated Patients Requiring Emergency Surgery or Intervention: Updated/Final Results From the RE-VERSE AD Study Conference Paper
- Impact of Rivaroxaban Alone or in Combination With Aspirin versus Aspirin in Preventing Graft Occlusion in Patients With CABG Surgery COMPASS CABG Conference Paper
- Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes Conference Paper
- Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes Conference Paper
- Improved Treatment Satisfaction Independent of Stroke and Bleeding Risk Among Patients Transitioned From a Vitamin K Antagonist to Rivaroxaban: A XANTUS-ACTS Analysis Conference Paper
- Intermittent Myocardial Stretch Elicits a Reduction in Left Ventricular Diastolic Compliance and Pathologic Characteristics of Heart Failure With Preserved Ejection Fraction in Swine Conference Paper
- Knowledge to Action: Rationale and Design of the Patient-Centred Care Transitions in Heart Failure (PACT-HF) Pragmatic Trial Conference Paper
- Marked Global Variability in Cost Effectiveness of Lipid-Lowering and Combination Antihypertensive Therapies in Primary Prevention: Analyses of the HOPE-3 Trial Conference Paper
- Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor in Patients With Cardiovascular Risk Factors: ASSERT II Conference Paper
- Randomized Trial of Short vs Ultra Short Radial Artery Clamp Time Post Trans-radial Cardiac Catheterization Conference Paper
- Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies Conference Paper
- Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies Conference Paper
- TRiCS III - An International Multicenter Randomized Trial of Transfusion Requirements in Cardiac Surgery Conference Paper
- Testosterone Levels and Risk for Cardiovascular Events - A Report From the ORIGIN (Outcome Reduction With an Initial Glargine Intervention) Trial Conference Paper
- The Effect of Blood Pressure and Cholesterol Lowering on Cognition Conference Paper
- The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial Conference Paper
- The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention -Insights From the CURRENTOASIS 7 Trial Conference Paper